Foundry Partners, LLC - IRADIMED CORP ownership

IRADIMED CORP's ticker is IRMD and the CUSIP is 46266A109. A total of 55 filers reported holding IRADIMED CORP in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Foundry Partners, LLC ownership history of IRADIMED CORP
ValueSharesWeighting
Q3 2021$2,090,000
-4.2%
62,225
-16.1%
0.08%0.0%
Q2 2021$2,181,000
-4.4%
74,170
-16.2%
0.08%0.0%
Q1 2021$2,281,000
+8.7%
88,495
-3.8%
0.08%
-8.5%
Q4 2020$2,098,000
+11.5%
92,015
+4.5%
0.08%
-9.9%
Q3 2020$1,882,000
+9.6%
88,025
+19.0%
0.09%
+8.3%
Q2 2020$1,717,00073,9900.08%
Other shareholders
IRADIMED CORP shareholders Q4 2020
NameSharesValueWeighting ↓
Nine Ten Capital Management LLC 783,066$30,814,0005.13%
Soleus Capital Management, L.P. 773,694$30,444,8593.15%
RK Capital 335,400$13,197,9902.90%
Capital Impact Advisors, LLC 19,390$762,9970.94%
Ranger Investment Management 205,692$8,093,9800.54%
Bares Capital Management 317,000$12,473,9500.44%
Hillsdale Investment Management Inc. 109,100$4,293,0850.37%
CORNERCAP INVESTMENT COUNSEL INC 37,007$1,456,2250.26%
Riverwater Partners LLC 6,234$245,3080.22%
RICE HALL JAMES & ASSOCIATES, LLC 72,271$2,843,8640.16%
View complete list of IRADIMED CORP shareholders